Pitfalls of using composite primary end points in the presence of competing risks.
Mell
Loren K
LK
Jeong
Jong-Hyeon
JH
D057186:Comparative Effectiveness Research; D023381:Endpoint Determination; D006801:Humans; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D011336:Probability; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012306:Risk; D016019:Survival Analysis